Lenacapavir, a long-acting injectable pre-exposure prophylaxis, has been recommended by the WHO to help protect high-risk ...

When it comes to a clinical study to evaluate the therapeutic effect of Shivagutika treatment in patients with HIV, it was ...

Lenacapavir, which was approved by the United States' Food and Drug Administration in June this year, is taken twice per year ...

The proposed cuts have caused concerns among some Senate Republicans, including Utah Sen. John Curtis, who may consider ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

This 2011 electron microscope image made available by the Centers for Disease Control shows HIV virions. On Wednesday, Sept.

As HIV cases continue to rise in the Philippines, especially among the youth, a new global development may offer hope in ...

Austinites impacted by HIV/AIDS have an opportunity to make their needs known at a town hall held by the Austin Area HIV ...

SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

U2 rock star Bono has been a prominent activist in the global fight against HIV/AIDS, including working with the George W.

The World Health Organization now recommends lenacapavir, a twice-yearly injectable HIV prevention drug, especially for high-risk groups. This endorsement arrives amidst funding concerns, with Gilead ...